 | • レポートコード：D0GIR-00747 • 出版社/出版日：GlobalInfoResearch / 2020年9月18日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、末期腎疾患治療の世界市場を広く調査・分析し、今後の市場展望をまとめております。末期腎疾患治療の種類別市場規模（移植、透析）、用途別市場規模（公立病院、私立病院）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Nipro Corporation、Cantel Medical、Medtronic、Fresenius Medical Care、Asahi Kasei Medical Co., Ltd.、Baxter International, Inc.、JMS、BD、B. Braun Melsungen AG、Nikkiso ・地域別グローバル市場分析 2015年-2020年 ・末期腎疾患治療の北米市場（アメリカ、カナダ、メキシコ） ・末期腎疾患治療のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・末期腎疾患治療のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・末期腎疾患治療の南米市場（ブラジル、アルゼンチン） ・末期腎疾患治療の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：移植、透析 ・用途別分析：公立病院、私立病院 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The End Stage Renal Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global End Stage Renal Disease Treatment sales will be xx in 2020 from End Stage Renal Disease Treatment million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global End Stage Renal Disease Treatment market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the End Stage Renal Disease Treatment industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on End Stage Renal Disease Treatment and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
End Stage Renal Disease Treatment market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, End Stage Renal Disease Treatment market has been segmented into:
Transplantation
Dialysis
By Application, End Stage Renal Disease Treatment has been segmented into:
Public Hospitals
Private Hospitals
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global End Stage Renal Disease Treatment market presented in the report. This section sheds light on the sales growth of different regional and country-level End Stage Renal Disease Treatment markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global End Stage Renal Disease Treatment market.
The report offers in-depth assessment of the growth and other aspects of the End Stage Renal Disease Treatment market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and End Stage Renal Disease Treatment Market Share Analysis
End Stage Renal Disease Treatment competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, End Stage Renal Disease Treatment sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the End Stage Renal Disease Treatment sales, revenue and market share for each player covered in this report.
The major players covered in End Stage Renal Disease Treatment are:
Nipro Corporation
Cantel Medical
Medtronic
Fresenius Medical Care
Asahi Kasei Medical Co., Ltd.
Baxter International, Inc.
JMS
BD
B. Braun Melsungen AG
Nikkiso
Among other players domestic and global, End Stage Renal Disease Treatment market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 End Stage Renal Disease Treatment Market Overview
1.1 Product Overview and Scope of End Stage Renal Disease Treatment
1.2 Classification of End Stage Renal Disease Treatment by Type
1.2.1 Global End Stage Renal Disease Treatment Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global End Stage Renal Disease Treatment Revenue Market Share by Type in 2019
1.2.3 Transplantation
1.2.4 Dialysis
1.3 Global End Stage Renal Disease Treatment Market by Application
1.3.1 Overview: Global End Stage Renal Disease Treatment Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Public Hospitals
1.3.3 Private Hospitals
1.4 Global End Stage Renal Disease Treatment Market by Regions
1.4.1 Global End Stage Renal Disease Treatment Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of End Stage Renal Disease Treatment (2015-2025)
1.4.3 North America (USA, Canada and Mexico) End Stage Renal Disease Treatment Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) End Stage Renal Disease Treatment Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) End Stage Renal Disease Treatment Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) End Stage Renal Disease Treatment Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) End Stage Renal Disease Treatment Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: End Stage Renal Disease Treatment Industry Impact
1.5.1 COVID-19 Potential Implications for the End Stage Renal Disease Treatment
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on End Stage Renal Disease Treatment
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Nipro Corporation
2.1.1 Nipro Corporation Details
2.1.2 Nipro Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Nipro Corporation SWOT Analysis
2.1.4 Nipro Corporation Product and Services
2.1.5 Nipro Corporation End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.2 Cantel Medical
2.2.1 Cantel Medical Details
2.2.2 Cantel Medical Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Cantel Medical SWOT Analysis
2.2.4 Cantel Medical Product and Services
2.2.5 Cantel Medical End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Medtronic SWOT Analysis
2.3.4 Medtronic Product and Services
2.3.5 Medtronic End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.4 Fresenius Medical Care
2.4.1 Fresenius Medical Care Details
2.4.2 Fresenius Medical Care Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Fresenius Medical Care SWOT Analysis
2.4.4 Fresenius Medical Care Product and Services
2.4.5 Fresenius Medical Care End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.5 Asahi Kasei Medical Co., Ltd.
2.5.1 Asahi Kasei Medical Co., Ltd. Details
2.5.2 Asahi Kasei Medical Co., Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Asahi Kasei Medical Co., Ltd. SWOT Analysis
2.5.4 Asahi Kasei Medical Co., Ltd. Product and Services
2.5.5 Asahi Kasei Medical Co., Ltd. End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.6 Baxter International, Inc.
2.6.1 Baxter International, Inc. Details
2.6.2 Baxter International, Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Baxter International, Inc. SWOT Analysis
2.6.4 Baxter International, Inc. Product and Services
2.6.5 Baxter International, Inc. End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.7 JMS
2.7.1 JMS Details
2.7.2 JMS Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 JMS SWOT Analysis
2.7.4 JMS Product and Services
2.7.5 JMS End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.8 BD
2.8.1 BD Details
2.8.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 BD SWOT Analysis
2.8.4 BD Product and Services
2.8.5 BD End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.9 B. Braun Melsungen AG
2.9.1 B. Braun Melsungen AG Details
2.9.2 B. Braun Melsungen AG Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 B. Braun Melsungen AG SWOT Analysis
2.9.4 B. Braun Melsungen AG Product and Services
2.9.5 B. Braun Melsungen AG End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
2.10 Nikkiso
2.10.1 Nikkiso Details
2.10.2 Nikkiso Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Nikkiso SWOT Analysis
2.10.4 Nikkiso Product and Services
2.10.5 Nikkiso End Stage Renal Disease Treatment Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global End Stage Renal Disease Treatment Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 End Stage Renal Disease Treatment Players Market Share
3.2.2 Top 10 End Stage Renal Disease Treatment Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global End Stage Renal Disease Treatment Revenue and Market Share by Regions
4.2 North America End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
4.3 Europe End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
4.5 South America End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
5 North America End Stage Renal Disease Treatment Revenue by Countries
5.1 North America End Stage Renal Disease Treatment Revenue by Countries (2015-2020)
5.2 USA End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
5.3 Canada End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
5.4 Mexico End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
6 Europe End Stage Renal Disease Treatment Revenue by Countries
6.1 Europe End Stage Renal Disease Treatment Revenue by Countries (2015-2020)
6.2 Germany End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
6.3 UK End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
6.4 France End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
6.5 Russia End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
6.6 Italy End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
7 Asia-Pacific End Stage Renal Disease Treatment Revenue by Countries
7.1 Asia-Pacific End Stage Renal Disease Treatment Revenue by Countries (2015-2020)
7.2 China End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
7.3 Japan End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
7.4 Korea End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
7.5 India End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
8 South America End Stage Renal Disease Treatment Revenue by Countries
8.1 South America End Stage Renal Disease Treatment Revenue by Countries (2015-2020)
8.2 Brazil End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
8.3 Argentina End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue End Stage Renal Disease Treatment by Countries
9.1 Middle East & Africa End Stage Renal Disease Treatment Revenue by Countries (2015-2020)
9.2 Saudi Arabia End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
9.3 UAE End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
9.4 Egypt End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
9.5 South Africa End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global End Stage Renal Disease Treatment Revenue and Market Share by Type (2015-2020)
10.2 Global End Stage Renal Disease Treatment Market Forecast by Type (2019-2024)
10.3 Transplantation Revenue Growth Rate (2015-2025)
10.4 Dialysis Revenue Growth Rate (2015-2025)
11 Global End Stage Renal Disease Treatment Market Segment by Application
11.1 Global End Stage Renal Disease Treatment Revenue Market Share by Application (2015-2020)
11.2 End Stage Renal Disease Treatment Market Forecast by Application (2019-2024)
11.3 Public Hospitals Revenue Growth (2015-2020)
11.4 Private Hospitals Revenue Growth (2015-2020)
12 Global End Stage Renal Disease Treatment Market Size Forecast (2021-2025)
12.1 Global End Stage Renal Disease Treatment Market Size Forecast (2021-2025)
12.2 Global End Stage Renal Disease Treatment Market Forecast by Regions (2021-2025)
12.3 North America End Stage Renal Disease Treatment Revenue Market Forecast (2021-2025)
12.4 Europe End Stage Renal Disease Treatment Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific End Stage Renal Disease Treatment Revenue Market Forecast (2021-2025)
12.6 South America End Stage Renal Disease Treatment Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa End Stage Renal Disease Treatment Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global End Stage Renal Disease Treatment Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of End Stage Renal Disease Treatment by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global End Stage Renal Disease Treatment Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market End Stage Renal Disease Treatment Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global End Stage Renal Disease Treatment Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Nipro Corporation Corporate Information, Location and Competitors
Table 7. Nipro Corporation End Stage Renal Disease Treatment Major Business
Table 8. Nipro Corporation End Stage Renal Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 9. Nipro Corporation SWOT Analysis
Table 10. Nipro Corporation End Stage Renal Disease Treatment Product and Solutions
Table 11. Nipro Corporation End Stage Renal Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Cantel Medical Corporate Information, Location and Competitors
Table 13. Cantel Medical End Stage Renal Disease Treatment Major Business
Table 14. Cantel Medical End Stage Renal Disease Treatment Total Revenue (USD Million) (2018-2019)
Table 15. Cantel Medical SWOT Analysis
Table 16. Cantel Medical End Stage Renal Disease Treatment Product and Solutions
Table 17. Cantel Medical End Stage Renal Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Medtronic Corporate Information, Location and Competitors
Table 19. Medtronic End Stage Renal Disease Treatment Major Business
Table 20. Medtronic End Stage Renal Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 21. Medtronic SWOT Analysis
Table 22. Medtronic End Stage Renal Disease Treatment Product and Solutions
Table 23. Medtronic End Stage Renal Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Fresenius Medical Care Corporate Information, Location and Competitors
Table 25. Fresenius Medical Care End Stage Renal Disease Treatment Major Business
Table 26. Fresenius Medical Care End Stage Renal Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 27. Fresenius Medical Care SWOT Analysis
Table 28. Fresenius Medical Care End Stage Renal Disease Treatment Product and Solutions
Table 29. Fresenius Medical Care End Stage Renal Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Asahi Kasei Medical Co., Ltd. Corporate Information, Location and Competitors
Table 31. Asahi Kasei Medical Co., Ltd. End Stage Renal Disease Treatment Major Business
Table 32. Asahi Kasei Medical Co., Ltd. End Stage Renal Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 33. Asahi Kasei Medical Co., Ltd. SWOT Analysis
Table 34. Asahi Kasei Medical Co., Ltd. End Stage Renal Disease Treatment Product and Solutions
Table 35. Asahi Kasei Medical Co., Ltd. End Stage Renal Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Baxter International, Inc. Corporate Information, Location and Competitors
Table 37. Baxter International, Inc. End Stage Renal Disease Treatment Major Business
Table 38. Baxter International, Inc. End Stage Renal Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 39. Baxter International, Inc. SWOT Analysis
Table 40. Baxter International, Inc. End Stage Renal Disease Treatment Product and Solutions
Table 41. Baxter International, Inc. End Stage Renal Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. JMS Corporate Information, Location and Competitors
Table 43. JMS End Stage Renal Disease Treatment Major Business
Table 44. JMS End Stage Renal Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 45. JMS SWOT Analysis
Table 46. JMS End Stage Renal Disease Treatment Product and Solutions
Table 47. JMS End Stage Renal Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. BD Corporate Information, Location and Competitors
Table 49. BD End Stage Renal Disease Treatment Major Business
Table 50. BD End Stage Renal Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 51. BD SWOT Analysis
Table 52. BD End Stage Renal Disease Treatment Product and Solutions
Table 53. BD End Stage Renal Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. B. Braun Melsungen AG Corporate Information, Location and Competitors
Table 55. B. Braun Melsungen AG End Stage Renal Disease Treatment Major Business
Table 56. B. Braun Melsungen AG End Stage Renal Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 57. B. Braun Melsungen AG SWOT Analysis
Table 58. B. Braun Melsungen AG End Stage Renal Disease Treatment Product and Solutions
Table 59. B. Braun Melsungen AG End Stage Renal Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Nikkiso Corporate Information, Location and Competitors
Table 61. Nikkiso End Stage Renal Disease Treatment Major Business
Table 62. Nikkiso End Stage Renal Disease Treatment Total Revenue (USD Million) (2017-2018)
Table 63. Nikkiso SWOT Analysis
Table 64. Nikkiso End Stage Renal Disease Treatment Product and Solutions
Table 65. Nikkiso End Stage Renal Disease Treatment Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Global End Stage Renal Disease Treatment Revenue (Million USD) by Players (2015-2020)
Table 67. Global End Stage Renal Disease Treatment Revenue Share by Players (2015-2020)
Table 68. Global End Stage Renal Disease Treatment Revenue (Million USD) by Regions (2015-2020)
Table 69. Global End Stage Renal Disease Treatment Revenue Market Share by Regions (2015-2020)
Table 70. North America End Stage Renal Disease Treatment Revenue by Countries (2015-2020)
Table 71. North America End Stage Renal Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 72. Europe End Stage Renal Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 73. Asia-Pacific End Stage Renal Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 74. South America End Stage Renal Disease Treatment Revenue by Countries (2015-2020)
Table 75. South America End Stage Renal Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 76. Middle East and Africa End Stage Renal Disease Treatment Revenue (Million USD) by Countries (2015-2020)
Table 77. Middle East and Africa End Stage Renal Disease Treatment Revenue Market Share by Countries (2015-2020)
Table 78. Global End Stage Renal Disease Treatment Revenue (Million USD) by Type (2015-2020)
Table 79. Global End Stage Renal Disease Treatment Revenue Share by Type (2015-2020)
Table 80. Global End Stage Renal Disease Treatment Revenue Forecast by Type (2021-2025)
Table 81. Global End Stage Renal Disease Treatment Revenue by Application (2015-2020)
Table 82. Global End Stage Renal Disease Treatment Revenue Share by Application (2015-2020)
Table 83. Global End Stage Renal Disease Treatment Revenue Forecast by Application (2021-2025)
Table 84. Global End Stage Renal Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. End Stage Renal Disease Treatment Picture
Figure 2. Global End Stage Renal Disease Treatment Revenue Market Share by Type in 2019
Figure 3. Transplantation Picture
Figure 4. Dialysis Picture
Figure 5. End Stage Renal Disease Treatment Revenue Market Share by Application in 2019
Figure 6. Public Hospitals Picture
Figure 7. Private Hospitals Picture
Figure 8. Global End Stage Renal Disease Treatment Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America End Stage Renal Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe End Stage Renal Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific End Stage Renal Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America End Stage Renal Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa End Stage Renal Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global End Stage Renal Disease Treatment Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global End Stage Renal Disease Treatment Revenue Share by Players in 2019
Figure 16. Global Top 5 Players End Stage Renal Disease Treatment Revenue Market Share in 2019
Figure 17. Global Top 10 Players End Stage Renal Disease Treatment Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global End Stage Renal Disease Treatment Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global End Stage Renal Disease Treatment Revenue Market Share by Regions (2015-2020)
Figure 21. Global End Stage Renal Disease Treatment Revenue Market Share by Regions in 2018
Figure 22. North America End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 23. Europe End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 25. South America End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 27. North America End Stage Renal Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 28. North America End Stage Renal Disease Treatment Revenue Market Share by Countries in 2019
Figure 29. USA End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 30. Canada End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 31. Mexico End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 32. Europe End Stage Renal Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 33. Europe End Stage Renal Disease Treatment Revenue Market Share by Countries in 2019
Figure 34. Germany End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 35. UK End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 36. France End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 37. Russia End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 38. Italy End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific End Stage Renal Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific End Stage Renal Disease Treatment Revenue Market Share by Countries in 2019
Figure 41. China End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 42. Japan End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 43. Korea End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 44. India End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 46. South America End Stage Renal Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 47. South America End Stage Renal Disease Treatment Revenue Market Share by Countries in 2019
Figure 48. Brazil End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 49. Argentina End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa End Stage Renal Disease Treatment Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa End Stage Renal Disease Treatment Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 53. UAE End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 54. Egypt End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 55. South Africa End Stage Renal Disease Treatment Revenue and Growth Rate (2015-2020)
Figure 56. Global End Stage Renal Disease Treatment Revenue Share by Type (2015-2020)
Figure 57. Global End Stage Renal Disease Treatment Revenue Share by Type in 2019
Figure 58. Global End Stage Renal Disease Treatment Market Share Forecast by Type (2021-2025)
Figure 59. Global Transplantation Revenue Growth Rate (2015-2020)
Figure 60. Global Dialysis Revenue Growth Rate (2015-2020)
Figure 61. Global End Stage Renal Disease Treatment Revenue Share by Application (2015-2020)
Figure 62. Global End Stage Renal Disease Treatment Revenue Share by Application in 2019
Figure 63. Global End Stage Renal Disease Treatment Market Share Forecast by Application (2021-2025)
Figure 64. Global Public Hospitals Revenue Growth Rate (2015-2020)
Figure 65. Global Private Hospitals Revenue Growth Rate (2015-2020)
Figure 66. Global End Stage Renal Disease Treatment Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global End Stage Renal Disease Treatment Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global End Stage Renal Disease Treatment Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America End Stage Renal Disease Treatment Revenue Market Forecast (2021-2025)
Figure 70. Europe End Stage Renal Disease Treatment Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific End Stage Renal Disease Treatment Revenue Market Forecast (2021-2025)
Figure 72. South America End Stage Renal Disease Treatment Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa End Stage Renal Disease Treatment Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
末期腎臓病の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The End-Stage Kidney Disease market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…- ニューカッスル病治療薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Newcastle Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Newcastle Disease…
- 感染症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Infectious Disease Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 5.1% in the forecast period of 2020 to 2025 and will expected to reach USD 59530 million by 2025, from USD 48760 million in 2019. The Infectiou…
- ブタ呼吸器疾患治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Swine Respiratory Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain…
- ICAD（頭蓋内アテローム性動脈硬化症）病理治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The ICAD (Intracranial Atherosclerotic Disease) Pathology Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global…